IP Verse

Bayer HealthCare Pharmaceuticals Inc. v. ScieGen Pharmaceuticals, Inc. - 1:25-cv-01283

Bayer HealthCare Pharmaceuticals Inc. v. ScieGen Pharmaceuticals, Inc. (Case No. 1:25-cv-01283), filed on Oct 20, 2025 in the District Court, D. Delaware involving patent infringement. This case involves patent infringement claims between the parties. Explore details about the litigants, key filings, and major docket updates.

Case Details

Case Number
1:25-cv-01283
Filing Date
Oct 20, 2025
Cause of Action
Patent Infringement
Status
-
Court
District Court, D. Delaware
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Bayer Pharma Aktiengesellschaft -
ScieGen Pharmaceuticals, Inc. -

Patents Involved

Patents not found - set an alert to get notified when patents are added.

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Oct 20, 2025Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer Aktiengesellschaft for Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma Aktiengesellschaft - filed by Bayer Aktiengesellschaft, Bayer HealthCare Pharmaceuticals Inc., Bayer Pharma Aktiengesellschaft. (jfm) (Entered: 10/20/2025)PACER Document
Oct 20, 2025Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) RE49,826. (jfm) (Entered: 10/20/2025)PACER Document
Oct 20, 2025Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 09/12/2025. Date of Expiration of Patent: 07/29/2035.Thirty Month Stay Deadline: 1/9/2029. (jfm) (Entered: 10/20/2025)PACER Document
Oct 20, 2025Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 10/20/2025)PACER Document
Oct 20, 2025COMPLAINT FOR PATENT INFRINGEMENT filed against ScieGen Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-4816989) - filed by Bayer Pharma Aktiengesellschaft, Bayer HealthCare Pharmaceuticals Inc., Bayer Aktiengesellschaft. (Attachments: # 1 Exhibits, A-F, # 2 Civil Cover Sheet)(jfm) (Entered: 10/20/2025)PACER Document
Oct 20, 2025No Summons Issued. (jfm)PACER Document